Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum. 1991

J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
Dartmouth Medical School, Hanover, New Hampshire 03756.

We describe the vaccination of Panamanian monkeys (Aotus sp.) with two recombinant blood stage antigens that each contain a portion of the N-terminal region of the SERA (serine repeat antigen) protein of the malaria parasite Plasmodium falciparum. We immunized with either a 262-amino-acid SERA fragment (SERA I) that contains amino acids 24 to 285 of the 989-amino-acid protein or a 483-amino-acid SERA fragment (SERA N) that contains amino acids 24 to 506 as part of a fusion protein with human gamma interferon. The recombinant proteins were shown to stimulate protective immunity when administered with complete and incomplete Freund adjuvant. Four of six immunized monkeys challenged by intravenous inoculation with blood stage P. falciparum developed parasitemias that were reduced by at least 1,000-fold. Two of six immunized monkeys developed parasitemias which were comparable to the lowest parasitemia in one of four controls and were 50- to 1,000-fold lower than in the other three controls.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens

Related Publications

J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
May 1993, Infection and immunity,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
May 1993, Infection and immunity,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
May 1990, Proceedings of the National Academy of Sciences of the United States of America,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
June 1970, Zeitschrift fur Tropenmedizin und Parasitologie,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
January 1986, Nature,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
February 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
April 1986, Infection and immunity,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
January 1992, Memorias do Instituto Oswaldo Cruz,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
December 1987, The Journal of parasitology,
J Inselburg, and D J Bzik, and W B Li, and K M Green, and J Kansopon, and B K Hahm, and I C Bathurst, and P J Barr, and R N Rossan
June 2002, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!